Led $2.7M seed round in Nome Bio, an AI-powered platform enabling rare disease patients to develop their own drugs.
Nome Bio is an AI-powered platform enabling rare disease patients to develop their own drugs by evaluating genetic data and coordinating the necessary resources for drug development
Nome Bio is an AI-powered platform enabling rare disease patients to develop their own drugs by evaluating genetic data and coordinating the necessary resources for drug development.